cdk dinaciclib Search Results


cdk inhibitors dinaciclib  (AstraZeneca ltd)
90
AstraZeneca ltd cdk inhibitors dinaciclib
Cdk Inhibitors Dinaciclib, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk inhibitors dinaciclib/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
cdk inhibitors dinaciclib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cdk inhibitors dinaciclib  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals cdk inhibitors dinaciclib
Cdk Inhibitors Dinaciclib, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk inhibitors dinaciclib/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
cdk inhibitors dinaciclib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cdk inhibitor dinaciclib  (Topscience Co Ltd)
90
Topscience Co Ltd cdk inhibitor dinaciclib
Western blot of BEL7402/5-FU cells with 5-FU treatment (NC) and <t>5-FU-Dinaciclib-combined</t> treatment (Dinaciclib). p-RB: phosphorylated RB; RB: total RB. (a) Western blot results of p-RB and RB. (b) Gray values of western blot results.
Cdk Inhibitor Dinaciclib, supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk inhibitor dinaciclib/product/Topscience Co Ltd
Average 90 stars, based on 1 article reviews
cdk inhibitor dinaciclib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
the cdk inhibitor sch 727965 (dinaciclib)  (Merck & Co)
90
Merck & Co the cdk inhibitor sch 727965 (dinaciclib)
Western blot of BEL7402/5-FU cells with 5-FU treatment (NC) and <t>5-FU-Dinaciclib-combined</t> treatment (Dinaciclib). p-RB: phosphorylated RB; RB: total RB. (a) Western blot results of p-RB and RB. (b) Gray values of western blot results.
The Cdk Inhibitor Sch 727965 (Dinaciclib), supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the cdk inhibitor sch 727965 (dinaciclib)/product/Merck & Co
Average 90 stars, based on 1 article reviews
the cdk inhibitor sch 727965 (dinaciclib) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Western blot of BEL7402/5-FU cells with 5-FU treatment (NC) and 5-FU-Dinaciclib-combined treatment (Dinaciclib). p-RB: phosphorylated RB; RB: total RB. (a) Western blot results of p-RB and RB. (b) Gray values of western blot results.

Journal: Disease Markers

Article Title: CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells

doi: 10.1155/2022/6907057

Figure Lengend Snippet: Western blot of BEL7402/5-FU cells with 5-FU treatment (NC) and 5-FU-Dinaciclib-combined treatment (Dinaciclib). p-RB: phosphorylated RB; RB: total RB. (a) Western blot results of p-RB and RB. (b) Gray values of western blot results.

Article Snippet: Cells treated with or without CDK inhibitor Dinaciclib (Topscience Biotechnology, Shanghai, China) were plated in 96-well plates at 2 × 10 3 cells per well.

Techniques: Western Blot

Quantity-effect relationship graph of BEL7402/5-FU cells with 5-FU treatment and 5-FU-Dinaciclib combined treatment. The X axis and Y axis show the log transformation of 5-FU concentration and the cell viability, respectively. Error bars show the SE.

Journal: Disease Markers

Article Title: CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells

doi: 10.1155/2022/6907057

Figure Lengend Snippet: Quantity-effect relationship graph of BEL7402/5-FU cells with 5-FU treatment and 5-FU-Dinaciclib combined treatment. The X axis and Y axis show the log transformation of 5-FU concentration and the cell viability, respectively. Error bars show the SE.

Article Snippet: Cells treated with or without CDK inhibitor Dinaciclib (Topscience Biotechnology, Shanghai, China) were plated in 96-well plates at 2 × 10 3 cells per well.

Techniques: Transformation Assay, Concentration Assay